Evidence map›Paper›PMID 31119102›Full record

ArticleFrontiers in cellular and infection microbiology2019

Ludmila P Polari, Pedro Paulo Carneiro, Michael Macedo, Paulo R L Machado, Phillip Scott, Edgar M Carvalho, Olívia Bacellar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. High glucose heightens vulnerability toEmerging microbes & infections · 2025
    Article
  4. Annexin A1 downregulatesFrontiers in immunology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Frontiers in immunology · 2023
    Article
  12. Review
  13. Article
  14. Microorganisms · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Pathogens (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Resistance AgainstFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Ludmila P PolariServiço de Imunologia, Complexo Hospitalar Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Pedro Paulo CarneiroServiço de Imunologia, Complexo Hospitalar Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Michael MacedoServiço de Imunologia, Complexo Hospitalar Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Paulo R L MachadoServiço de Imunologia, Complexo Hospitalar Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Phillip ScottDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Edgar M CarvalhoInstituto Nacional de Ciência e Tecnologia de Doenças Tropicais - INCT-DT (CNPq/MCT), Salvador, Brazil.
Olívia BacellarServiço de Imunologia, Complexo Hospitalar Universitário Prof. Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais · BRComplexo Hospitalar Universitário Professor Edgard Santos · BRFundação Oswaldo Cruz · BRUniversidade Federal da Bahia · BRUniversity of Pennsylvania · US

Funding

Inflammation in the Pathogenesis of Disseminated LeishmaniasisU01AI136032 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 2017 to 2021
$1.6M
NIAID NIH HHS U01 AI136032
6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) caused by infection with

Indexed as

AdultCells, CulturedFemaleGene ExpressionHumansInterleukin-10Leishmania braziliensisLeishmaniasis, CutaneousMaleMiddle AgedMonocytesToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alphaYoung AdultIL10 protein, humanInterleukin-10TLR2 protein, humanTLR4 protein, humanTNF protein, humanToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alphahuman cutaneous leishmaniasisinflammationLeishmania braziliensismonocytes subsetstoll like receptor 2toll like receptor 4

Identifiers

PMID31119102
PMCPMC6507514
OpenAlexW2943179680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.